Allyson Cole Strauss

Title: Innovations by Allyson Cole Strauss

Introduction

Allyson Cole Strauss is a prominent inventor based in Philadelphia, PA (US). She has made significant contributions to the field of biotechnology, particularly in the development of anti-fungal agents. With a total of 2 patents, her work has the potential to impact medical treatments and improve patient outcomes.

Latest Patents

One of her latest patents focuses on anti-fungal agents and methods of identifying and using the same. This patent discloses substantially pure C. albicans topoisomerase I protein. It includes nucleic acid molecules that encode this protein, as well as recombinant expression vectors that comprise a nucleic acid sequence encoding C. albicans topoisomerase I protein. Additionally, it describes host cells that contain these recombinant expression vectors. The patent also covers fragments of nucleic acid molecules with sequences encoding C. albicans topoisomerase I protein and oligonucleotide molecules that are complementary to these fragments. Furthermore, it includes antibodies that bind to an epitope on C. albicans topoisomerase I protein and methods for identifying inhibitors of this protein.

Career Highlights

Allyson Cole Strauss is affiliated with Thomas Jefferson University, where she conducts her research and development work. Her innovative approaches and discoveries have positioned her as a key figure in her field.

Collaborations

She has collaborated with notable colleagues, including Eric B. Kmiec and David L. Gerhold, who have contributed to her research endeavors.

Conclusion

Allyson Cole Strauss exemplifies the spirit of innovation in biotechnology through her patents and research at Thomas Jefferson University. Her work on anti-fungal agents showcases her commitment to advancing medical science and improving health outcomes.